Literature DB >> 22684644

Prognostic role of C-reactive protein and interleukin-6 in dialysis patients: a systematic review and meta-analysis.

Wei Zhang1, Jing He, Fengmei Zhang, Chengjin Huang, Ying Wu, Yijie Han, Wei Zhang1, Yulan Zhao.   

Abstract

Inflammation may be associated with mortality in dialysis patients. This study aims to summarize the prognostic value of two common inflammatory markers, C-reactive protein (CRP) and interleukin-6 (IL-6) for dialysis outcome. A total of 109 CRP studies and 22 IL-6 studies were identified from PubMed and EMBASE after systematic searching and assessment. The combined hazard ratios (HRs) of CRP and IL-6 for mortality were analyzed. For all-cause mortality (ACM), both CRP and IL-6 could significantly predict the outcome, with the pooled HRs of 1.142 (95%CI: 1.118-1.166) and 1.152 (95%CI: 1.094-1.214) for CRP and IL-6, respectively. For cardiovascular disease mortality (CVDM), the pooled HR of CRP (1.182, 95%CI: 1.134-1.232) was close to that of IL-6 (1.181, 95%CI: 1.068-1.307). Therefore, elevated levels of CRP or IL-6 were significantly associated with higher ACM and higher CVDM in dialysis patients. The predictive value of the inflammatory biomarkers may be useful in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684644     DOI: 10.5301/jn.5000169

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  24 in total

1.  The Effects of Synbiotic Supplementation on Metabolic Status in Diabetic Patients Undergoing Hemodialysis: a Randomized, Double-Blinded, Placebo-Controlled Trial.

Authors:  Alireza Soleimani; Alireza Motamedzadeh; Malihe Zarrati Mojarrad; Fereshteh Bahmani; Elaheh Amirani; Vahidreza Ostadmohammadi; Maryam Tajabadi-Ebrahimi; Zatollah Asemi
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

2.  Risk factors for decreased upper-limb muscle strength and its impact on survival in maintenance hemodialysis patients.

Authors:  Qian Zhang; Jiaying Zhang; Weichen Zhang; Mengjing Wang; Bihong Huang; Minmin Zhang; Jing Chen
Journal:  Int Urol Nephrol       Date:  2020-05-04       Impact factor: 2.370

3.  The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation.

Authors:  Nikolas Itaru Wada; Lisa P Jacobson; Joseph B Margolick; Elizabeth Crabb Breen; Bernard Macatangay; Sudhir Penugonda; Otoniel Martínez-Maza; Jay H Bream
Journal:  AIDS       Date:  2015-02-20       Impact factor: 4.177

4.  Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2.

Authors:  Liliana M Pedruzzi; Ludmila F M F Cardozo; Julio B Daleprane; Milena B Stockler-Pinto; Elisa B Monteiro; Maurilo Leite; Nosratola D Vaziri; Denise Mafra
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

Review 5.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 6.  Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations.

Authors:  Srisakul Chirakarnjanakorn; Sankar D Navaneethan; Gary S Francis; W H Wilson Tang
Journal:  Int J Cardiol       Date:  2017-01-04       Impact factor: 4.164

7.  Ultrasound Modulates the Splenic Neuroimmune Axis in Attenuating AKI.

Authors:  Joseph C Gigliotti; Liping Huang; Amandeep Bajwa; Hong Ye; Eric H Mace; John A Hossack; Kambiz Kalantari; Tsuyoshi Inoue; Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

Review 8.  Cardiovascular risk factors in children on dialysis: an update.

Authors:  Uwe Querfeld; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2018-10-31       Impact factor: 3.714

9.  Rationale and design of technology assisted stepped collaborative care intervention to improve patient-centered outcomes in hemodialysis patients (TĀCcare trial).

Authors:  Maria-Eleni Roumelioti; Jennifer L Steel; Jonathan Yabes; Kevin E Vowles; Yoram Vodovotz; Scott Beach; Bruce Rollman; Steven D Weisbord; Mark L Unruh; Manisha Jhamb
Journal:  Contemp Clin Trials       Date:  2018-09-09       Impact factor: 2.226

Review 10.  Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.

Authors:  Wei-Jie Li; Xu-Miao Chen; Xiao-Ying Nie; Jing Zhang; Yun-Jiu Cheng; Xiao-Xiong Lin; Su-Hua Wu
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.